ASX 200 healthcare shares provided some pain relief today. Here's why

The healthcare sector ended Thursday as the best performer on the ASX.

A man in a wheelchair stretches both arms into the air in success.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The ASX 200 Health Care index closed slightly lower on Thursday but still outperformed the broader market
  • The smaller cap healthcare shares helped make it the best-performing sector on the ASX
  • Global healthcare index leader CSL closed just 0.27% lower having been in positive territory for much of the day

A number of ASX shares in the S&P/ASX 200 Health Care Index (ASX: XHJ) outperformed the broader market today.

The benchmark S&P/ASX 200 Index (ASX: XJO) backtracked yet again, ending Thursday's session 1.97% lower at 6,568.1 points.

In contrast, the healthcare sector was the best performer on the ASX today, falling just 0.19% after spending much of the day in the green.

What's happening in the ASX 200 healthcare sector?

The biggest and most heavily weighted share price within the ASX 200 healthcare sector is CSL Limited (ASX: CSL).

The global biotech outperformed the ASX 200, closing just 0.27% lower at $269.06. Much like the healthcare index, it was in positive territory for most of the day before retreating late in the session.

However, it was the smaller cap companies such as Paradigm Biopharmaceuticals Ltd (ASX: PAR) and Recce Pharmaceuticals Ltd (ASX: RCE) that led the charge. They gained 10.29% and 9.88%, respectively.

Paradigm reported a positive release before market open, stating it had received official acceptance of an Australian patent application. However, there was no fresh news out of Recce Pharmaceuticals.

Meanwhile, the Race Oncology Ltd (ASX: RAC) share price gained 4.84% after the company released the latest interim results from its preclinical cardioprotection program.

While the ASX 200 Health Care index has rebounded 3.2% this week, it's still down 12% year-to-date.

The ASX has been hit hard in recent weeks following high inflation levels and aggressive rate hikes.

During the March quarter, inflation rose by 5.1%, the highest increase in many years. This led the Reserve Bank of Australia to ramp up the official cash rate by 0.5% to 0.85%.

Foolish takeaway

Investing in an ASX-index tracking fund is considered a much safer alternative than picking an individual company.

This is because the sector is relatively impervious to wild swings from any one share price.

Furthermore, it's worth noting that an index has historically provided long-term stable growth.

It is often the most boring investments that reap the largest rewards.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Index investing

Young boy in business suit punches the air as he finishes ahead of another boy in a box car race.
Index investing

Want to outperform 82% of professional fund managers? Buy these ASX ETFs

It's easier than you'd think to beat most ASX fund managers.

Read more »

Man smiling at a laptop because of a rising share price.
Index investing

The ultimate guide to investing in the Vanguard Australian Shares Index ETF (VAS) for maximum returns

This strategy should get you the best bang for your buck with VAS.

Read more »

A little girl holds on to her piggy bank, giving it a really big hug.
Index investing

If I could only buy and hold a single ASX stock right now, this would be it

This ETF would be my first buy in today's market.

Read more »

Ten smiling business people wave to the camera after receiving some winning company news.
ETFs

Vanguard Australian Shares Index ETF has lifted 20% in a year. Which stocks have contributed most to its rise?

This popular ASX ETF seeks to track the performance of the S&P/ASX 300 Index before fees.

Read more »

Happy young woman saving money in a piggy bank.
ETFs

Did you know these ASX stocks are in the Vanguard Australian Shares Index ETF (VAS)?

The VAS ETF is an index fund that tracks the 300 biggest listed companies by market capitalisation.

Read more »

A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
Bank Shares

Should I dump my holding in CBA shares and buy an ASX S&P 500 tracker instead?

Deciding between CBA and an S&P 500 tracker is a no-brainer for me.

Read more »

Three young people in business attire sit around a desk and discuss.
Opinions

Want to start investing? These 3 ETFs can be a great first step

The first step can be the most important, but it doesn't need to the hardest.

Read more »

Woman laying with $100 notes around her, symbolising dividends.
Index investing

If you invested $5,000 in the Betashares Nasdaq 100 ETF (NDQ) 5 years ago, here's how much you'd have today

The gains that this index fund has delivered have been nothing short of extraordinary.

Read more »